Noriyuki Miyaue, Hayato Yabe, & Masahiro Nagai. (2023). Serum GDF-15 Levels in Patients with Parkinson's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy. MDPI AG.
Chicago Style (17th ed.) CitationNoriyuki Miyaue, Hayato Yabe, and Masahiro Nagai. Serum GDF-15 Levels in Patients with Parkinson's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy. MDPI AG, 2023.
MLA (9th ed.) CitationNoriyuki Miyaue, et al. Serum GDF-15 Levels in Patients with Parkinson's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.